Result Summary for 101468/248
| Protocol ID: | 101468/248 |
| Clinical Study ID: | 101468/248 |
| Official Title: | An Open-Label Extension Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
